SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-004685
Filing Date
2015-08-13
Accepted
2015-08-13 17:16:26
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_081115.htm 10-Q 648211
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8070
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8062
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4323
  Complete submission text file 0001171843-15-004685.txt   2808052

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20150630.xml EX-101.INS 366686
6 XBRL SCHEMA FILE prto-20150630.xsd EX-101.SCH 35500
7 XBRL CALCULATION FILE prto-20150630_cal.xml EX-101.CAL 30172
8 XBRL DEFINITION FILE prto-20150630_def.xml EX-101.DEF 238024
9 XBRL LABEL FILE prto-20150630_lab.xml EX-101.LAB 208338
10 XBRL PRESENTATION FILE prto-20150630_pre.xml EX-101.PRE 254809
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 151051609
SIC: 2836 Biological Products, (No Diagnostic Substances)